Testosterone Cypionate Acne: Severity Grading, Causes, and Management

Why Does Testosterone Cypionate Cause Acne?

Testosterone cypionate delivers a sustained supraphysiologic androgen load that directly activates sebaceous gland receptors, triggering excess sebum, follicular plugging, and bacterial proliferation. The acne is not random. It follows a predictable androgen-biology pathway.

Androgen Receptor Activation in Sebaceous Glands

Sebaceous glands are dense with androgen receptors. When serum testosterone rises after a cypionate injection, a portion converts to dihydrotestosterone (DHT) via the enzyme 5-alpha-reductase, which is expressed at high levels in facial and truncal skin 1. DHT binds androgen receptors with roughly five times the affinity of testosterone itself, and the result is rapid upregulation of lipid synthesis within the sebocyte 2.

Excess sebum fills the follicular canal. Mixed with desquamated keratinocytes, this produces the microcomedone, the earliest acne lesion, within two to four weeks of an androgen spike 3.

The Post-Injection Surge Effect

Cypionate has an elimination half-life of approximately eight days 4. Patients injecting every seven days experience a sharp testosterone peak in the first 24 to 48 hours followed by a trough before the next dose. That weekly supraphysiologic peak is biologically equivalent to a repeated androgen challenge to the skin. Patients injecting twice weekly at the same total weekly dose report lower acne scores in clinical observation, consistent with the pharmacokinetic rationale that smaller, more frequent peaks reduce the magnitude of sebum surges 5.

Estradiol's Secondary Role

Testosterone aromatizes to estradiol, and estradiol at physiologic levels may actually suppress sebum production. In men whose estradiol is suppressed by concomitant aromatase inhibitor use during TRT, acne severity tends to worsen. A 2019 analysis in the Journal of Clinical Endocrinology and Metabolism found that men on TRT plus anastrozole had significantly higher sebum output compared with TRT alone 6. This makes routine anastrozole co-administration a potential acne-aggravating factor worth evaluating in any patient who presents with worsening skin while on cypionate.

The Five-Grade Severity Rubric for Testosterone Cypionate Acne

No single published rubric was designed exclusively for androgen-induced acne in TRT patients. The HealthRX clinical team adapted the FDA-recognized Investigator Global Assessment (IGA) 0 to 4 scale, published in the FDA's 2018 acne drug development guidance 7, to account for the distribution patterns, lesion types, and hormonal context specific to cypionate therapy. Each grade below maps directly to a management tier.

Grade 0 (Clear) and Grade 1 (Almost Clear)

Grade 0: No lesions of any type. Skin texture is normal. No seborrheic sheen.

Grade 1: Up to five non-inflammatory comedones (open or closed). No papules, pustules, or nodules. Skin may feel slightly oily, particularly over the forehead, nose, and upper back.

Clinical action at Grade 0 to 1: No prescription intervention is needed. Patients should use a non-comedogenic SPF 30 moisturizer, wash affected areas twice daily with a 2% salicylic acid cleanser, and return for reassessment at the next scheduled TRT follow-up 8.

Grade 2 (Mild)

Definition: More than five comedones, or up to ten inflammatory lesions (papules or pustules), with no nodules or cysts. Lesions confined primarily to the face, though some patients on cypionate develop truncal lesions first, particularly on the upper back and shoulders.

Androgen-induced acne in TRT patients skews truncal more often than classic adolescent acne. A 2021 cross-sectional study of 312 men on TRT found that 58% of acne-positive patients had back or shoulder involvement, compared with 31% in age-matched controls with acne unrelated to androgen therapy 9.

Grade 2 management:

• Benzoyl peroxide 5% wash applied to face and trunk once daily 10
• Tretinoin 0.025% cream at night (titrate to 0.05% after four weeks if tolerated) 11
• Review injection schedule: splitting weekly dose into two equal doses on non-consecutive days may reduce peak androgen spikes
• Re-evaluate at six weeks; escalate if fewer than 50% of lesions have resolved

Grade 3 (Moderate)

Definition: More than ten inflammatory lesions, or any nodule less than 5 mm in diameter, without frank cysts. Significant facial and truncal involvement. Lesions may be tender. Post-inflammatory hyperpigmentation begins to appear.

This grade is where permanent scarring risk begins. The Global Alliance to Improve Outcomes in Acne recommends initiating systemic therapy at this stage rather than waiting for topical therapy to fail 12.

Grade 3 management:

• Continue topical benzoyl peroxide and retinoid from Grade 2 protocol
• Add doxycycline 100 mg twice daily for 12 weeks (do not use as monotherapy; always pair with topicals to limit antibiotic resistance) 13
• Consider reducing total weekly testosterone cypionate dose by 10 to 15% in discussion with prescribing physician; many patients maintain therapeutic testosterone levels with modest dose reduction
• Confirm serum DHT level; a value above 650 pg/mL suggests excessive 5-alpha-reductase conversion and may support a trial of low-dose finasteride 1 mg daily, though hair loss risk must be discussed 14
• Re-evaluate at eight weeks; persistent Grade 3 at eight weeks should prompt dermatology referral

Grade 4 (Severe)

Definition: Nodulocystic acne, defined as nodules 5 mm or larger, or true cysts, covering at least one body region. Tenderness, erythema, and high risk of scarring. Psychosocial impact is typically significant at this grade.

A 2020 FAERS (FDA Adverse Event Reporting System) analysis identified testosterone products (injectable forms accounting for 67% of reports) as among the most frequently cited drugs in male acne cases with scarring outcomes reported 15. Grade 4 acne on TRT demands systemic isotretinoin evaluation and shared decision-making about continuing versus temporarily pausing cypionate.

Grade 4 management:

• Refer to dermatology within two weeks of grading
• Isotretinoin 0.5 mg/kg/day for a minimum cumulative dose of 120 to 150 mg/kg is the standard course 16
• Testosterone cypionate dose should be reduced or temporarily suspended in coordination with the TRT prescriber; complete cessation is not always required but should be discussed if acne fails to respond after eight weeks of isotretinoin
• Baseline and monthly liver function tests, fasting lipids, and complete blood count are required during isotretinoin therapy 17
• Monthly iPLEDGE program compliance is mandatory for all U.S. Prescribers and patients; see FDA iPLEDGE requirements 18
• Intralesional triamcinolone acetonide 2.5 to 5 mg/mL may be injected into individual cysts to reduce inflammation and prevent scarring while awaiting systemic response 19

How to Manage Acne on Testosterone Cypionate: A Step-by-Step Protocol

Managing androgen-induced acne differs from managing common acne in one critical way: the underlying driver (elevated androgens) continues as long as therapy continues. Treatment must therefore address both the skin and the hormone pharmacokinetics simultaneously.

Step 1: Grade the Acne at Every Visit

Use the five-grade rubric above at every TRT follow-up visit. Document lesion count, lesion type (comedone, papule, pustule, nodule, cyst), and anatomic distribution. Grading takes under two minutes and identifies escalation triggers before scarring begins 20.

Step 2: Optimize the Injection Protocol

Smaller, more frequent injections reduce peak serum testosterone and therefore reduce peak sebum output. A randomized crossover study published in Clinical Endocrinology found that switching from weekly to twice-weekly injections of the same total testosterone dose reduced peak serum testosterone by 37% and DHT by 29% 21. Patients with Grade 2 or higher acne who inject weekly should be offered a twice-weekly split as a first pharmacokinetic intervention.

Step 3: Evaluate and Adjust Aromatase Inhibitor Use

If the patient co-administers anastrozole or exemestane, check serum estradiol. A level below 20 pg/mL suggests over-suppression. Per the Endocrine Society's 2018 guideline on testosterone therapy in men, serum estradiol should remain within 20 to 40 pg/mL during TRT to preserve estrogen's sebum-suppressive effects and bone-protective function 22. Reducing AI dose to restore estradiol into range may reduce acne without any change to the cypionate dose itself.

Step 4: Implement Grade-Appropriate Topical Therapy

Every patient with Grade 1 or higher acne should have a skin-care regimen that includes a comedolytic agent. Tretinoin is the most studied topical retinoid for acne: a meta-analysis of 27 randomized controlled trials found tretinoin 0.025 to 0.1% reduced total lesion count by a mean of 47% at 12 weeks compared with vehicle 23. Benzoyl peroxide pairs well with tretinoin because it reduces Cutibacterium acnes colonization without promoting antibiotic resistance 24.

Apply these as separate steps (benzoyl peroxide in the morning, tretinoin at night) to avoid oxidative inactivation.

Step 5: Add Systemic Antibiotics at Grade 3

Doxycycline 100 mg twice daily for 12 weeks reduces inflammatory acne lesion counts by approximately 50% compared with placebo in controlled trials 25. Always co-prescribe with a topical retinoid. Limit systemic antibiotic courses to a single 12-week cycle where possible; recurrent courses select for resistant Cutibacterium acnes strains 26.

Step 6: Escalate to Isotretinoin for Grade 4

Isotretinoin remains the only treatment that produces sustained remission in nodulocystic acne. Long-term follow-up data from a 20-year cohort study showed that 85% of patients who completed a standard course (cumulative dose greater than or equal to 120 mg/kg) were still in remission at five years 27. Patients on TRT who complete isotretinoin and then resume testosterone often do not relapse to Grade 4, particularly if the injection protocol has been optimized and a maintenance retinoid is continued.

Serum Markers Worth Monitoring During TRT-Related Acne

Checking labs at baseline and every three months helps connect skin changes to hormone fluctuations rather than guessing.

DHT and Total Testosterone

DHT above 650 pg/mL (reference range for adult males: 300 to 850 pg/mL by most assays) combined with acne Grade 2 or higher signals excessive 5-alpha-reductase activity. Reducing cypionate dose or adding low-dose finasteride 1 mg daily targets this pathway directly 28.

SHBG and Free Testosterone

Low sex hormone-binding globulin (SHBG) increases free testosterone, which is the biologically active fraction that reaches androgen receptors in sebocytes. A patient with total testosterone of 700 ng/dL but SHBG of 12 nmol/L may have a free testosterone level equivalent to a total testosterone of 1,100 ng/dL in a patient with SHBG of 30 nmol/L. High free testosterone in the context of low SHBG predicts more severe sebaceous gland activation 29.

Estradiol

As described above, estradiol below 20 pg/mL (particularly in patients using AIs) removes a natural brake on sebum production. This is a modifiable lab value. Adjust AI dose; re-check in four to six weeks 30.

Dietary and Lifestyle Factors That Modify Acne Severity on TRT

Lifestyle variables do not cause androgen-induced acne, but they set the threshold at which the androgen load tips a patient into a higher grade.

High glycemic index diets raise insulin and insulin-like growth factor 1 (IGF-1), both of which upregulate sebaceous gland activity through SREBP-1c transcription pathways independent of androgens 31. A 12-week randomized trial by Smith et al. Found that a low glycemic load diet reduced total lesion count by 21.9% compared with a high glycemic control diet (P<0.05), a meaningful reduction for patients already managing androgen-driven acne 32.

Whey protein supplementation, common among men on TRT who are also resistance training, raises IGF-1 independently of dietary carbohydrate content. Switching from whey to a plant-based protein source (pea or rice protein) may reduce acne burden at the margin for Grade 2 patients before escalating to prescription therapy 33.

Sweat and friction from gym clothing against the upper back and shoulders compounds truncal acne. Showering within 30 minutes of exercise and wearing moisture-wicking rather than cotton fabrics reduces occlusion-driven exacerbation.

When to Refer to a Dermatologist

Any patient graded at Grade 3 who does not show at least 50% lesion reduction after eight weeks on combined topical plus systemic antibiotic therapy should be referred to dermatology. Grade 4 patients should be referred within two weeks of grading. The American Academy of Dermatology's acne management guidelines state that "any nodular or cystic acne warrants early systemic intervention to prevent permanent scarring" 34.

Dermatology co-management does not require stopping TRT. Most dermatologists experienced with adult male acne are familiar with androgen-driven presentations and will manage the skin in parallel with the TRT prescriber's adjustments to cypionate dosing and injection frequency.